https://www.selleckchem.com/pr....oducts/crenolanib-cp
5-99.75] days versus 16 [9-34] days, median [interquartile range], P=.001). Patients with disabling neurological deficits prior to hospital admission or who received vasoactive drugs during their ICU stay have a higher risk of readmission to the ICU, which increases hospital stay and mortality. Patients with disabling neurological deficits prior to hospital admission or who received vasoactive drugs during their ICU stay have a higher risk of readmission to the ICU, which increases hospital stay and mortality. Hemoglobinopa
Like
Comment
Share
